mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.1 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |